Article FDA Thank You FDA updates guidance on developing drugs for Covid-19, replacing pandemic-era version
Agency IQ
DECEMBER 1, 2023
Now, the FDA has issued its first post-PHE version of this guidance Although the previous version of the guidance was revised to remain in effect until March 7, 2024, it has now been replaced. drug-drug interactions) and intrinsic factors (e.g.,
Let's personalize your content